← stocks-llm Find companies like VEEV →

Veeva Systems (VEEV)

Health Care · Life Sciences Cloud Software

Veeva is the dominant cloud software and data platform powering the global life sciences industry from drug development through commercialization, with AI-enhanced solutions and a 16% annual revenue growth trajectory.

What Veeva Systems does

Veeva is the leading provider of industry cloud solutions for the global life sciences industry, serving pharmaceutical, biotechnology, medical device, and diagnostics companies. The company offers four major product categories—Development Cloud, Quality Cloud, Commercial Cloud, and Data Cloud—spanning cloud software, AI, data, and business consulting to support customers from R&D through commercialization. Veeva's solutions help life sciences companies develop and bring products to market faster, market and sell more effectively, and maintain regulatory compliance.

Themes: ["life sciences cloud solutions","clinical trial software","drug development","regulatory compliance","clinical data management","pharmaceutical commercialization","AI in pharma","quality and manufacturing","patient engagement"]

Fundamentals

Ask why VEEV looks like this →

Key risks (from latest filing)

["Revenue concentration in life sciences industry exposes company to regulatory changes, drug development cycles, and customer consolidation","High customer acquisition costs and dependency on deeper customer penetration; R&D solutions serve many early-stage pre-commercial companies that may not reach commercialization","Stock price declined 31.6% over the past year despite profitability and revenue growth, indicating market sentiment pressure or competitive concerns"]

See VEEV's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-09. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-08.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.